Is remission a more realistic goal in psoriatic arthritis?
作者信息
Saber Tajvur P, Fearon Ursula, Veale Douglas J
机构信息
Dublin Academic Medical Centre, Department of Rheumatology, Bone and Joint Unit, St Vincent's University Hospital and the Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Ireland.
出版信息
Ther Adv Musculoskelet Dis. 2011 Feb;3(1):3-7. doi: 10.1177/1759720X10389847.
Abstract
摘要
相似文献
1
Is remission a more realistic goal in psoriatic arthritis?
Ther Adv Musculoskelet Dis. 2011 Feb;3(1):3-7. doi: 10.1177/1759720X10389847.
2
Clinical remission in rheumatoid arthritis and psoriatic arthritis.
Clin Exp Rheumatol. 2018 Sep-Oct;36(5):900-910. Epub 2018 Mar 16.
3
Remission of psoriatic arthritis after etanercept discontinuation: analysis of patients' clinical characteristics leading to disease relapse.
Int J Immunopathol Pharmacol. 2013 Jul-Sep;26(3):833-8. doi: 10.1177/039463201302600333.
4
Very Low Disease Activity, DAPSA Remission, and Impact of Disease in a Spanish Population with Psoriatic Arthritis.
J Rheumatol. 2019 Jul;46(7):710-715. doi: 10.3899/jrheum.180460. Epub 2019 Feb 1.
5
Sustained remission with methotrexate monotherapy after 22-week induction treatment with TNF-alpha inhibitor and methotrexate in early psoriatic arthritis: an open-label extension of a randomized placebo-controlled trial.
Arthritis Res Ther. 2019 Sep 14;21(1):208. doi: 10.1186/s13075-019-1998-4.
6
Need for Improvement in Current Treatment of Psoriatic Arthritis: Study of an Outpatient Clinic Population.
J Rheumatol. 2017 Apr;44(4):431-436. doi: 10.3899/jrheum.160973. Epub 2017 Feb 1.
7
Comparison of Composite Indices Tailored for Psoriatic Arthritis Treated with csDMARD and bDMARD: A Cross-sectional Analysis of a Longitudinal Cohort.
J Rheumatol. 2017 Aug;44(8):1159-1164. doi: 10.3899/jrheum.170112. Epub 2017 Jun 1.
8
Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study.
Biologics. 2012;6:201-6. doi: 10.2147/BTT.S31145. Epub 2012 Jul 12.
9
Ultrasonographic evaluation in psoriatic arthritis is of major importance in evaluating disease activity.
Ann Rheum Dis. 2016 Dec;75(12):2108-2113. doi: 10.1136/annrheumdis-2015-208806. Epub 2016 Apr 18.
10
Assessment of Response to Treatment, Remission, and Minimal Disease Activity in Axial Psoriatic Arthritis Treated with Tumor Necrosis Factor Inhibitors.
J Rheumatol. 2016 May;43(5):918-23. doi: 10.3899/jrheum.151404. Epub 2016 Mar 15.
本文引用的文献
1
Remission in psoriatic arthritis: is it possible and how can it be predicted?
Arthritis Res Ther. 2010;12(3):R94. doi: 10.1186/ar3021. Epub 2010 May 18.
2
Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register.
Rheumatology (Oxford). 2010 Apr;49(4):697-705. doi: 10.1093/rheumatology/kep423. Epub 2010 Jan 7.
3
Defining remission in rheumatoid arthritis: results of an initial American College of Rheumatology/European League Against Rheumatism consensus conference.
Arthritis Rheum. 2009 May 15;61(5):704-10. doi: 10.1002/art.24392.
4
Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment.
Ann Rheum Dis. 2010 Jan;69(1):48-53. doi: 10.1136/ard.2008.102053.
5
Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study.
Arthritis Res Ther. 2009;11(1):R7. doi: 10.1186/ar2591. Epub 2009 Jan 14.
6
Mortality in psoriatic arthritis.
Clin Exp Rheumatol. 2008 Sep-Oct;26(5 Suppl 51):S62-5.
7
Remission in psoriatic arthritis.
Curr Rheumatol Rep. 2008 Aug;10(4):297-302. doi: 10.1007/s11926-008-0048-z.
8
Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial.
Lancet. 2008 Aug 2;372(9636):375-82. doi: 10.1016/S0140-6736(08)61000-4. Epub 2008 Jul 16.
9
Evidence-based review of biologic markers as indicators of disease progression and remission in rheumatoid arthritis.
Rheumatol Int. 2007 Jul;27(9):793-806. doi: 10.1007/s00296-007-0357-y. Epub 2007 May 16.
10
Outcome measures in psoriatic arthritis.
J Rheumatol. 2007 May;34(5):1159-66.
Zotero 插件